(Q44003644)

28 November 2017

title

Adherence to preventive statin therapy according to socioeconomic position (English)

1 reference

28 November 2017

0 references

1 reference

2

1 reference

28 November 2017

3

1 reference

28 November 2017

4

1 reference

28 November 2017

Helle Wallach-Kildemoes

object named as

Helle Wallach-Kildemoes

series ordinal

1

0 references

publication date

16 April 2013

1 reference

European Journal of Clinical Pharmacology

28 November 2017

published in

1 reference

28 November 2017

volume

69

1 reference

28 November 2017

issue

8

1 reference

28 November 2017

page(s)

1553-1563

1 reference

The statin studies: from targeting hypercholesterolaemia to targeting the high-risk patient

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1488-6

European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1488-6

European guidelines on cardiovascular disease prevention in clinical practice: executive summary

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1488-6

Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1488-6

Accuracy and impact of risk assessment in the primary prevention of cardiovascular disease: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1488-6

Are lipid-lowering guidelines evidence-based?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1488-6

Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1488-6

Is the high-risk strategy to prevent cardiovascular disease equitable? A pharmacoepidemiological cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1488-6

Is opportunistic disease prevention in the consultation ethically justifiable?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1488-6

American, British and European recommendations for statins in the primary prevention of cardiovascular disease applied to British men studied prospectively

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1488-6

Primary care: is there enough time for prevention?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1488-6

Effectiveness and efficiency of different guidelines on statin treatment for preventing deaths from coronary heart disease: modelling study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1488-6

Statin prescription in men and women at cardiovascular risk: to whom and when?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1488-6

Estimating the high risk group for cardiovascular disease in the Norwegian HUNT 2 population according to the 2003 European guidelines: modelling study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1488-6

Explaining the social gradient in coronary heart disease: comparing relative and absolute risk approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1488-6

Health inequalities among British civil servants: the Whitehall II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1488-6

Widening socioeconomic inequalities in mortality in six Western European countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1488-6

Primary prevention of cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1488-6

Evaluating the impact of population and high-risk strategies for the primary prevention of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1488-6

Revisiting Rose: strategies for reducing coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1488-6

Closing the gap in a generation: health equity through action on the social determinants of health

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1488-6

Drug utilization according to reason for prescribing: a pharmacoepidemiologic method based on an indication hierarchy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1488-6

Impact of adherence to statins on coronary artery disease in primary prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1488-6

Persistence and determinants of statin therapy among middle-aged patients free of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1488-6

Persistence and determinants of statin therapy among middle-aged patients for primary and secondary prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1488-6

Non-adherence to statin therapy: a major challenge for preventive cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1488-6

High persistence of statin use in a Danish population: compliance study 1993-1998.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1488-6

Adherence to statin therapy and patients' cardiovascular risk: a pharmacoepidemiological study in Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1488-6

Use of statins and beta-blockers after acute myocardial infarction according to income and education

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1488-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1488-6

Do immigrants from Turkey, Pakistan and Yugoslavia receive adequate medical treatment with beta-blockers and statins after acute myocardial infarction compared with Danish-born residents? A register-based follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1488-6

Do immigrants from Turkey, Pakistan and Ex-Yugoslavia with newly diagnosed type 2 diabetes initiate recommended statin therapy to the same extent as Danish-born residents? A nationwide register study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1488-6

Suboptimal statin adherence and discontinuation in primary and secondary prevention populations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1488-6

Adherence to statin therapy under drug cost sharing in patients with and without acute myocardial infarction: a population-based natural experiment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1488-6

Introduction to Danish (nationwide) registers on health and social issues: structure, access, legislation, and archiving

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1488-6

The Danish National Prescription Registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1488-6

Construction of drug treatment episodes from drug-dispensing histories is influenced by the gap length

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1488-6

The Danish National Patient Register.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1488-6

A comparison of two methods for estimating refill adherence to statins in Sweden: the RARE project

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1488-6

Using prescription registries to define continuous drug use: how to fill gaps between prescriptions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1488-6

Driving forces behind increasing cardiovascular drug utilization: a dynamic pharmacoepidemiological model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1488-6

Statin adherence and the risk of major coronary events in patients with diabetes: a nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1488-6

Determinants of self-reported medicine underuse due to cost: a comparison of seven countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1488-6

The effect of cost on adherence to prescription medications in Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1488-6

Pricing and reimbursement of drugs in Denmark.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1488-6

The demand for statin: the effect of copay on utilization and compliance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1488-6

Association between copayment and adherence to statin treatment initiated after coronary heart disease hospitalization: a longitudinal, retrospective, cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1488-6

The influence of income on health: views of an epidemiologist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1488-6

Cost-effectiveness of enhancing adherence to therapy with statins in the setting of primary cardiovascular prevention. Evidence from an empirical approach based on administrative databases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1488-6

Predictors of statin adherence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1488-6

Patient, physician, and payment predictors of statin adherence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1488-6

The effects of adherence and persistence on clinical outcomes in patients treated with statins: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1488-6

Healthy user and related biases in observational studies of preventive interventions: a primer for physicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1488-6

Statin rebound or withdrawal syndrome: does it exist?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1488-6

Statin discontinuation in high-risk patients: a systematic review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1488-6

A competing risk approach for the European Heart SCORE model based on cause-specific and all-cause mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1488-6

Gender Differences in Utilization of Preventive Care Services in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-013-1488-6

Physician Follow-up and Provider Continuity Are Associated With Long-term Medication Adherence

21 January 2018

1 reference

12 December 2020

Impact of statin copayments on adherence and medical care utilization and expenditures

1 reference

12 December 2020

Statin discontinuation: an underestimated risk?

1 reference

12 December 2020

Denmark health system review.

1 reference

12 December 2020

Significance of the invasive strategy after acute myocardial infarction on prognosis and secondary preventive medication: a nationwide study of 6364 women and 11,915 men.

1 reference

12 December 2020

The healthy adherer effect

1 reference

12 December 2020

Will screening individuals at high risk of cardiovascular events deliver large benefits? No

1 reference

12 December 2020

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

12 December 2020

Effect of statin withdrawal on frequency of cardiac events after vascular surgery

1 reference

12 December 2020

Follow-up lipid tests and physician visits are associated with improved adherence to statin therapy

1 reference

12 December 2020

10.1007/S00228-013-1488-6

Identifiers

DOI

1 reference

28 November 2017

1 reference